2018-2023 Global Pericarditis Market Report (Status and Outlook)

August 2018 | 115 pages | ID: 26D48659E20EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Pericarditis market for 2018-2023.

Pericarditis is inflammation of the pericardium (the fibrous sac surrounding the heart). Symptoms typically include sudden onset of sharp chest pain. The pain may also be felt in the shoulders, neck, or back. It is typically better sitting up and worse with lying down or breathing deep. Other symptoms may include fever, weakness, palpitations, and shortness of breath. Occasionally onset of symptoms is gradual.
Treatment in most cases is with NSAIDs and possibly colchicine. Steroids may be used if those are not appropriate. Typically symptoms improve in a few days to weeks but can occasionally last months. Complications can include cardiac tamponade, myocarditis, and constrictive pericarditis. It is a less common cause of chest pain. About 3 per 10,000 people are affected per year. Those most commonly affected are males between the ages of 20 and 50. Up to 30% of those affected have more than one episode.
Over the next five years, LPI(LP Information) projects that Pericarditis will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares and growth opportunities of Pericarditis market by product type, application, key companies and key regions.

To calculate the market size, LP Information considers value generated from the sales of the following segments:

Segmentation by product type:

• Acute Pericarditis
• Chronic Pericarditis

Segmentation by application:

• Hospitals & Clinics
• Medical Institutes
• Research Organization

We can also provide the customized separate regional or country-level reports, for the following regions:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:

• Pfizer
• Astrazeneca
• Bayer
• Reckitt Benckiser
• Perkinelmer
• Fujifilm
• Merck Sharp & Dohme
• Allergan

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Pericarditis market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Pericarditis market by identifying its various subsegments.
• Focuses on the key global Pericarditis players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Pericarditis with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the size of Pericarditis submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Pericarditis Market Size 2013-2023
  2.1.2 Pericarditis Market Size CAGR by Region
2.2 Pericarditis Segment by Type
  2.2.1 Acute Pericarditis
  2.2.2 Chronic Pericarditis
  2.2.3 Recurrent Pericarditis
2.3 Pericarditis Market Size by Type
  2.3.1 Global Pericarditis Market Size Market Share by Type (2013-2018)
  2.3.2 Global Pericarditis Market Size Growth Rate by Type (2013-2018)
2.4 Pericarditis Segment by Application
  2.4.1 Hospitals & Clinics
  2.4.2 Medical Institutes
  2.4.3 Research Organization
2.5 Pericarditis Market Size by Application
  2.5.1 Global Pericarditis Market Size Market Share by Application (2013-2018)
  2.5.2 Global Pericarditis Market Size Growth Rate by Application (2013-2018)

3 GLOBAL PERICARDITIS BY PLAYERS

3.1 Global Pericarditis Market Size Market Share by Players
  3.1.1 Global Pericarditis Market Size by Players (2016-2018)
  3.1.2 Global Pericarditis Market Size Market Share by Players (2016-2018)
3.2 Global Pericarditis Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 PERICARDITIS BY REGIONS

4.1 Pericarditis Market Size by Regions
4.2 Americas Pericarditis Market Size Growth
4.3 APAC Pericarditis Market Size Growth
4.4 Europe Pericarditis Market Size Growth
4.5 Middle East & Africa Pericarditis Market Size Growth

5 AMERICAS

5.1 Americas Pericarditis Market Size by Countries
5.2 Americas Pericarditis Market Size by Type
5.3 Americas Pericarditis Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Pericarditis Market Size by Countries
6.2 APAC Pericarditis Market Size by Type
6.3 APAC Pericarditis Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Pericarditis by Countries
7.2 Europe Pericarditis Market Size by Type
7.3 Europe Pericarditis Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Pericarditis by Countries
8.2 Middle East & Africa Pericarditis Market Size by Type
8.3 Middle East & Africa Pericarditis Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 GLOBAL PERICARDITIS MARKET FORECAST

10.1 Global Pericarditis Market Size Forecast (2018-2023)
10.2 Global Pericarditis Forecast by Regions
  10.2.1 Global Pericarditis Forecast by Regions (2018-2023)
  10.2.2 Americas Market Forecast
  10.2.3 APAC Market Forecast
  10.2.4 Europe Market Forecast
  10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
  10.3.1 United States Market Forecast
  10.3.2 Canada Market Forecast
  10.3.3 Mexico Market Forecast
  10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
  10.4.1 China Market Forecast
  10.4.2 Japan Market Forecast
  10.4.3 Korea Market Forecast
  10.4.4 Southeast Asia Market Forecast
  10.4.5 India Market Forecast
  10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
  10.5.1 Germany Market Forecast
  10.5.2 France Market Forecast
  10.5.3 UK Market Forecast
  10.5.4 Italy Market Forecast
  10.5.5 Russia Market Forecast
  10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
  10.6.1 Egypt Market Forecast
  10.6.2 South Africa Market Forecast
  10.6.3 Israel Market Forecast
  10.6.4 Turkey Market Forecast
  10.6.5 GCC Countries Market Forecast
10.7 Global Pericarditis Forecast by Type
10.8 Global Pericarditis Forecast by Application

11 KEY PLAYERS ANALYSIS

11.1 Pfizer
  11.1.1 Company Details
  11.1.2 Pericarditis Product Offered
  11.1.3 Pfizer Pericarditis Revenue, Gross Margin and Market Share (2016-2018)
  11.1.4 Main Business Overview
  11.1.5 Pfizer News
11.2 Astrazeneca
  11.2.1 Company Details
  11.2.2 Pericarditis Product Offered
  11.2.3 Astrazeneca Pericarditis Revenue, Gross Margin and Market Share (2016-2018)
  11.2.4 Main Business Overview
  11.2.5 Astrazeneca News
11.3 Bayer
  11.3.1 Company Details
  11.3.2 Pericarditis Product Offered
  11.3.3 Bayer Pericarditis Revenue, Gross Margin and Market Share (2016-2018)
  11.3.4 Main Business Overview
  11.3.5 Bayer News
11.4 Reckitt Benckiser
  11.4.1 Company Details
  11.4.2 Pericarditis Product Offered
  11.4.3 Reckitt Benckiser Pericarditis Revenue, Gross Margin and Market Share (2016-2018)
  11.4.4 Main Business Overview
  11.4.5 Reckitt Benckiser News
11.5 Perkinelmer
  11.5.1 Company Details
  11.5.2 Pericarditis Product Offered
  11.5.3 Perkinelmer Pericarditis Revenue, Gross Margin and Market Share (2016-2018)
  11.5.4 Main Business Overview
  11.5.5 Perkinelmer News
11.6 Fujifilm
  11.6.1 Company Details
  11.6.2 Pericarditis Product Offered
  11.6.3 Fujifilm Pericarditis Revenue, Gross Margin and Market Share (2016-2018)
  11.6.4 Main Business Overview
  11.6.5 Fujifilm News
11.7 Merck Sharp & Dohme
  11.7.1 Company Details
  11.7.2 Pericarditis Product Offered
  11.7.3 Merck Sharp & Dohme Pericarditis Revenue, Gross Margin and Market Share (2016-2018)
  11.7.4 Main Business Overview
  11.7.5 Merck Sharp & Dohme News
11.8 Allergan
  11.8.1 Company Details
  11.8.2 Pericarditis Product Offered
  11.8.3 Allergan Pericarditis Revenue, Gross Margin and Market Share (2016-2018)
  11.8.4 Main Business Overview
  11.8.5 Allergan News

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Table Product Specifications of Pericarditis
Figure Pericarditis Report Years Considered
Figure Market Research Methodology
Figure Global Pericarditis Market Size Growth Rate 2013-2023 ($ Million